Who owns ELOXX PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Eloxx Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Eloxx Pharmaceuticals stock

Who bought or sold ELOXX PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Siren 400k $5.6M 100% Jun 2026
 View chart
Samsara BioCapital 400k $5.6M 100% Jun 2026
 View chart
Nantahala Capital Management 400k $5.6M 100% Jun 2026
 View chart
Standard Life Aberdeen 400k $6.1M 0% Sep 2026
 View chart
EcoR1 Capital 400k $5.6M 100% Jun 2026
 View chart
Stonepine Capital Management 397k $5.5M 100% Jun 2026
 View chart
Vanguard Capital Management 79k $1.1M 100% Jun 2026
 View chart
Geode Capital Management 20k $305k 100% Sep 2026
 View chart
Vanguard Fiduciary Trust 11k $147k 100% Jun 2026
 View chart
Seven Grand Managers 10k $139k 100% Jun 2026
 View chart
Vanguard Global Advisers 718.00 $10k 100% Jun 2026
 View chart
UBS Group 637.00 $8.8k 100% Jun 2026
 View chart
Wells Fargo & Company 126.00 $1.7k 100% Jun 2026
 View chart
Royal Bank of Canada 98.00 $1.0k 100% Jun 2026
 View chart
Pioneer Family Office 96.00 $1.5k 0% Sep 2026
 View chart
Altshuler Shaham 25.00 $347.000000 100% Jun 2026
 View chart
Old Point Trust & Financial Services N A 5.00 $77.000000 0% Sep 2026
 View chart
Activest Wealth Management 4.00 $61.000000 0% Sep 2026
 View chart
SBI Securities 2.00 $31.000000 0% Sep 2026
 View chart

Who sold out of Eloxx Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Barclays Jun 2026 12.00 $167.000400